Stock ledger
$TAK Insider Trading
Takeda Pharmaceutical Company Limited
4
Alerts Sent
50%
Hit Rate Here
0
Insider Buys 30d
1
Insider Sells 30d
This page is InsiderWatch’s own record for TAK: every alert we sent on this stock, scored against real market prices, plus recent insider buying and selling reported to the SEC on Form 4.
Price and Our Alerts
$TAK price
Daily closing prices
3M change
+22.2%
1Y high
$19.05
1Y low
$13.23
Our alerts
4
in this window
Prices from public market data and may be delayed. Markers show the days our alerts on this stock fired. Not investment advice.
Our Alerts on $TAK
2 alerts on TAK sent and pending: awaiting the next market close before the result appears here.
| Sent (ET) | Call | Alert | Result |
|---|---|---|---|
| Aug 28, 5:39 PM | BULLISH | FDA approves first-in-class polycythemia vera drug rusfertide | +1.1% ✓ hit |
| Aug 12, 9:51 PM | BEARISH | Nine Takeda insiders sell $8.1M in a week | +5.4% ✗ miss |
Every alert we sent on TAK is listed once scored, hits and misses alike. Result is the stock’s move from the alert to the graded exit of its catalyst window.
Recent Insider Activity
Open-market buys and sells in TAK by the company’s own officers, directors, and large holders, as reported to the SEC on Form 4 in roughly the last 30 days. New to the filing? Read what a Form 4 is and what the transaction codes mean.
Daily buy vs sell dollars
Open-market insider filings that passed the significance gates, last 30 days
Bought
$0
30 days
Sold
$640K
30 days
Net flow
-$640K
selling leads
Active days
1
with gated filings
| Filed (ET) | Insider | Action | Value |
|---|---|---|---|
| Sep 15 | Duprey Lauren RusckowskiChief Transformation Officer | SELL | $640k |
| Aug 19 | Greenway Nicola Deidre PetalChief Human Resources Officer | SELL | $235k |
| Aug 12 | Farajallah Awny Samaan BotrosChief Medical Officer | SELL | $240k |
| Aug 12 | Pacheco Rhonda JanicePresident, U.S. Business Unit | SELL | $289k |
| Aug 12 | Duprey Lauren RusckowskiChief Transformation Officer | SELL | $814k |
| Aug 12 | Plump Andrew StewartPresident, R&D | SELL | $2.8M |
| Aug 12 | Pignagnoli Agosti MarcelloHead, Strat. & Port. Dev | SELL | $393k |
| Aug 12 | Bitetti Teresa MariePresident, OBU | SELL | $855k |
| Aug 12 | Ricci GabrieleChief Data & Tech. Officer | SELL | $429k |
| Aug 12 | Kim Julie So-YoungPresident and CEO | SELL | $1.5M |
| Aug 12 | Platford Giles RichardPresident, IBU | SELL | $532k |
| Aug 12 | Furney Natalie Anne MarieGlobal General Counsel | SELL | $528k |
| Aug 12 | Shannon Elaine MaryPres., Global Supply & Quality | SELL | $357k |
| Aug 12 | Greenway Nicola Deidre PetalChief Human Resources Officer | SELL | $606k |
Sourced from public SEC Form 4 filings. Buys shown are open-market purchases; routine grants and plan sales are filtered out before a trade reaches this log.
See the latest alerts across all stocks, the complete scored track record, this week’s insider buying, or the congress trading tracker.
Get the Next TAK Alert When It Fires.
Everything here is already graded and public. Subscribers got it the minute it fired. Pro members get every alert; Watchlist members get the ones on stocks they follow. Free for 7 days, cancel any time.
Try Free for 7 DaysPast performance is not indicative of future results. Directional scoring measures a catalyst-matched window on daily closing prices and does not reflect fees, slippage, taxes, or execution. InsiderWatch is an informational service based on publicly available information only and is not financial, investment, legal, or tax advice. Outcomes are scored automatically against public market data by our own systems and are not independently audited.